Objective
To evaluate the potential impact of a standardized preoperative algorithm on outcomes of patients with suspected ovarian cancer.
Methods
From January 1 to December 31, 2013, patients with suspected ovarian cancer were triaged to primary debulking surgery (PDS) or neoadjuvant chemotherapy/interval debulking surgery (NACT/IDS) based on a comprehensive review of preoperative clinical data as part of a quality improvement (QI) project. Demographics, surgical and postoperative data were collected.
Results
110 newly diagnosed ovarian cancer patients were identified: 68 (62%) underwent PDS with an 85% optimal debulking rate. The 30-day readmission rate was 14.7% with a 2.9% 60-day mortality rate. 42 patients (38%) underwent NACT. Two patients (4.8%) died prior to receiving NACT. 35 patients have undergone IDS with an 89% optimal debulking rate. The 30-day readmission rate was 8.5% with a 5.7% 60-day mortality rate after IDS.
Conclusions
Although difficult to predict which patients will undergo optimal debulking at the time of PDS, surgical morbidity and mortality can be decreased by utilizing NACT in select patients. The initiation of a QI project has contributed to an improvement in patient outcomes at our institution.